Pfizer Inc
CIK
78003
Location
New York, NY
Portfolio Value
Small
$253,428,635
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,701
/ 8,603
▲ 277
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+14.3%
Period ended 3 months ago
Filed May 12, 2026 · 58d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+44.6%
SPY
+24.0%
Annualised alpha
+13.5%
Max drawdown
−34.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
16 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
23.9%
+5.3 pts
Top 5
79.6%
+2.6 pts
Top 10
96.4%
+0.9 pts
HHI
1,521
Moderately concentrated+225
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $253,428,635 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
5 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ORIC | Oric Pharmaceuticals, Inc. | −595,943 | 4,780,401 | $60,567,680 | |
| QTTB | Q32 Bio Inc. | −176,159 | 101,618 | $652,387 | |
| ZURA | Zura Bio Ltd | −131,109 | 2,838,913 | $16,891,532 | |
| CELC | Celcuity Inc. | −53,754 | 295,652 | $33,745,719 | |
| NXTC | NextCure, Inc. | −4,292 | 153,354 | $1,637,820 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AGMB | Agomab Therapeutics NV | 75,000 | $786,750 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 715,295 | $815,436 | |
| No positions match the current search. | ||||
16 positions ·
$253,428,635 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 4,780,401 | $60,567,680 | 23.90% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
Held | 22,032,040 | $53,758,177 | 21.21% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Held | 3,457,815 | $36,652,839 | 14.46% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 295,652 | $33,745,719 | 13.32% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Reduced | 2,838,913 | $16,891,532 | 6.67% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Held | 1,875,000 | $13,593,750 | 5.36% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Held | 7,032,770 | $10,267,843 | 4.05% | |
| CRBU |
Caribou Biosciences, Inc.
Healthcare
|
Held | 4,690,431 | $8,911,818 | 3.52% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 2,362,348 | $5,527,894 | 2.18% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 505,645 | $4,277,756 | 1.69% | |
| CRDF |
Cardiff Oncology, Inc.
Healthcare
|
Held | 2,411,575 | $3,906,751 | 1.54% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Held | 953,834 | $2,231,971 | 0.88% | |
| NXTC |
NextCure, Inc.
Healthcare
|
Reduced | 153,354 | $1,637,820 | 0.65% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
NEW | 75,000 | $786,750 | 0.31% | |
| QTTB |
Q32 Bio Inc.
Healthcare
|
Reduced | 101,618 | $652,387 | 0.26% | |
| DNA |
Ginkgo Bioworks Holdings, Inc.
Healthcare
|
Held | 2,928 | $17,948 | 0.01% |